What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 6 minute read Pharma Industry News How real-world evidence and pediatric studies may determine BRIUMVI’s ceiling in relapsing multiple sclerosis Find out how real-world data and pediatric studies could define the long-term ceiling for TG Therapeutics’ BRIUMVI in relapsing multiple sclerosis. bySoujanya RaviFebruary 9, 2026